Literature DB >> 9366669

Histopathologic study of eyes after iodine I 125 episcleral plaque irradiation for uveal melanoma.

M A Saornil1, M R Fisher, R J Campbell, D M Robertson, J D Earle, R C Eagle, J A Shields, C L Shields, S R Chandra, D M Albert.   

Abstract

OBJECTIVES: To describe the histopathologic findings attributable to irradiation in eyes with uveal malignant melanoma treated with iodine I 125 brachytherapy and to compare these findings with those reviewed in a previous study that compared histopathologic findings in eyes enucleated after proton beam teletherapy with those seen in eyes in a nonirradiated control group.
METHODS: The slides from 22 eyes with uveal melanoma that had undergone enucleation after the administration of 125I brachytherapy were studied. The histopathologic features of the tumor and the retina were graded. Results were compared with findings from a previously reported group of 47 proton beam-treated eyes and its control group.
RESULTS: Patient age, time between irradiation and enucleation, and ciliary body involvement were similar for the 125I brachytherapy-treated group and the proton beam-treated group and its control group. This allows comparison of the histopathologic findings. Comparing the 125I brachytherapy- and proton beam-treated groups, most histopathologic features were similar with nominally statistically significant differences only for cell type, number of mitotic figures, and fibrous metaplasia of the retinal pigment epithelium adjacent to the tumor.
CONCLUSIONS: Irradiation of uveal melanoma induces changes in the tumor and in the surrounding retina. Brachytherapy and charged particle therapy are the 2 principal methods of irradiation. This study demonstrates that similar changes are produced by 125I plaque irradiation and proton beam irradiation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9366669     DOI: 10.1001/archopht.1997.01100160565006

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  6 in total

1.  Effects of proton beam irradiation on uveal melanomas: a comparative study of Ki-67 expression in irradiated versus non-irradiated melanomas.

Authors:  C Chiquet; J D Grange; L Ayzac; P Chauvel; L M Patricot; M Devouassoux-Shisheboran
Journal:  Br J Ophthalmol       Date:  2000-01       Impact factor: 4.638

2.  Infiltrative Intraocular Conjunctival Squamous Cell Carcinoma after Local Resection and Brachytherapy: Clinical and Pathological Findings.

Authors:  Magnolia Trinidad Cano-Suárez; María Antonia Saornil-Álvarez; Ciro García-Álvarez; Francisco López-Lara; Jesús María Frutos-Baraja; Elena García-Lagarto
Journal:  Ocul Oncol Pathol       Date:  2017-03-04

3.  Histological study of choroidal malignant melanoma treated by carbon ion radiotherapy.

Authors:  Masatoshi Tsuji; Katsuaki Kimura; Hiroshi Tsuji; Masamichi Goto; Hiroshi Yoshikawa; Taiji Sakamoto
Journal:  Jpn J Ophthalmol       Date:  2007-04-06       Impact factor: 2.447

4.  Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: an EORTC ocular oncology group study.

Authors:  J Pe'er; F H Stefani; S Seregard; T Kivela; P Lommatzsch; J U Prause; B Sobottka; B Damato; I Chowers
Journal:  Br J Ophthalmol       Date:  2001-10       Impact factor: 4.638

5.  Episcleral brachytherapy for uveal melanoma: analysis of 136 cases.

Authors:  Ciro García-Álvarez; María Antonia Saornil; Francisco López-Lara; Ana Almaraz; María Fe Muñoz; Jesús Frutos-Baraja; Yerena Muiños
Journal:  Clin Transl Oncol       Date:  2012-05       Impact factor: 3.405

6.  Vascular perfusion of choroidal melanoma by 3.0 tesla magnetic resonance imaging.

Authors:  Bruce M Buerk; Jose S Pulido; Ignacio Chiong; Robert Folberg; Deepak P Edward; Mark T Duffy; Keith R Thulborn
Journal:  Trans Am Ophthalmol Soc       Date:  2004
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.